Frontiers in Immunology SJR and Scopus Metrics: What the Numbers Actually Tell Authors
Frontiers in Immunology has a stronger Scopus profile than many authors assume, but the real submission question is fit within a broad section-led OA journal.
Associate Professor, Immunology & Infectious Disease
Author context
Specializes in manuscript preparation and peer review strategy for immunology and infectious disease research, with 10+ years evaluating submissions to top-tier journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: Frontiers in Immunology has a real upper-tier Scopus profile for a broad immunology journal. Current Scopus-linked browser data reports a 2024 SJR of 1.941, a CiteScore of 10.8, and Q1 standing. That confirms visibility and legitimacy, but the submission decision still depends more on section fit, paper maturity, and your tolerance for a broad Frontiers-style editorial model than on the quartile alone.
The core metric picture
Metric | 2024 value | What it tells you |
|---|---|---|
SJR | 1.941 | Prestige-weighted influence is strong for a broad OA immunology title |
CiteScore | 10.8 | Four-year citation performance is solid |
SNIP | 1.259 | Impact remains above field-normalized baseline |
Quartile | Q1 | The journal remains in the top Scopus tier for the category |
JCR context | Impact factor 5.9 | Web of Science tells a similar upper-mid to upper-tier story |
The useful reading is that Frontiers in Immunology is not a weak fallback journal. It is a visible, well-indexed broad journal that still sits clearly below the most selective immunology flagships.
What the metrics actually help with
They help position the journal honestly:
- stronger than many routine immunology journals on visibility and citation reach
- weaker on editorial scarcity than Nature Immunology, Immunity, or other top flagships
- useful when the paper needs broad immunology reach more than top-end exclusivity
That is valuable when the shortlist includes Frontiers in Immunology, Journal of Immunology, Frontiers in Cellular and Infection Microbiology, or other broad field journals.
What the metrics do not answer
They do not tell you:
- whether the paper fits the right Frontiers section
- whether the manuscript is polished enough for broad external review
- whether another immunology journal would better reach the actual reader community
- whether the team still wants to take one more shot at a more selective journal first
Those are still the real submission questions.
Why the profile matters for authors
At this SJR and CiteScore level, Frontiers in Immunology clearly has real literature presence. The journal benefits from:
- a large, broad immunology readership
- strong discoverability across subfields
- an open-access model that keeps papers visible
- a section-led structure that can accommodate many kinds of immunology work
That does not make it an elite scarcity journal. It makes it a strong broad-access one. For many papers, that is exactly the right product. For others, it is a sign the journal may be too broad.
What should drive the submission decision instead
The better question is whether the manuscript is truly a Frontiers in Immunology paper.
That is why the better next reads are:
- Frontiers in Immunology submission guide
- Frontiers in Immunology impact factor
- Frontiers in Immunology acceptance rate
- Is Frontiers in Immunology a good journal?
If the section fit is clear and the paper benefits from broad immunology exposure, the metrics support the choice. If the real need is tighter brand signaling or a narrower expert audience, the metrics are already telling you to think harder.
Practical verdict
Frontiers in Immunology has a strong enough Scopus profile to be taken seriously as a broad immunology venue. That makes it a rational option for papers that are solid, complete, and better served by breadth and discoverability than by elite editorial scarcity.
But the useful takeaway is still fit, not reassurance. If the section match is vague or the novelty story is still too soft for a final journal call, the metric does not save the submission strategy. A free Manusights scan is the fastest way to pressure-test that before you commit.
- Frontiers in Immunology submission guide, Manusights.
Sources
- 1. Frontiers in Immunology journal browser entry, TU Dresden.
- 2. Frontiers in Immunology metrics page, JRank.
- 3. Frontiers in Immunology journal page, Frontiers.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.